X-139561565-C-T

Variant summary

Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PS4PVS1_StrongPP4_ModeratePM2_Supporting

This summary comes from the ClinGen Evidence Repository: The F9 c.880C>T (Arg294Ter) variant occurs in exon 8/8 of the F9 gene, and NMD is not predicted. PVS1_Strong is applied based on truncation of the Peptidase S1 domain. This variant is completely absent from gnomAD v2.1.1 and v3.1.1, meeting PM2_Supporting criteria. Over 90 patients have been reported in the literature and the EAHAD database with hemophilia B in the moderate-severe range and history of inhibitors to factor replacement products are reported, meeting PP4_Moderate and PS4_Very strong (selected PMIDs: 29296726, 8217825, 8314564). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_VeryStrong, PVS1_Strong, PP4_Moderate, PM2_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA255344/MONDO:0010604/080

Frequency

Genomes: not found (cov: 23)

Consequence

F9
NM_000133.4 stop_gained

Scores

2
1
1

Clinical Significance

Pathogenic reviewed by expert panel P:8

Conservation

PhyloP100: 1.09

Publications

13 publications found
Variant links:
Genes affected
F9 (HGNC:3551): (coagulation factor IX) This gene encodes vitamin K-dependent coagulation factor IX that circulates in the blood as an inactive zymogen. This factor is converted to an active form by factor XIa, which excises the activation peptide and thus generates a heavy chain and a light chain held together by one or more disulfide bonds. The role of this activated factor IX in the blood coagulation cascade is to activate factor X to its active form through interactions with Ca+2 ions, membrane phospholipids, and factor VIII. Alterations of this gene, including point mutations, insertions and deletions, cause factor IX deficiency, which is a recessive X-linked disorder, also called hemophilia B or Christmas disease. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Sep 2015]
F9 Gene-Disease associations (from GenCC):
  • hemophilia B
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • mild hemophilia B
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • moderately severe hemophilia B
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • severe hemophilia B
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • symptomatic form of hemophilia B in female carriers
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • thrombophilia, X-linked, due to factor 9 defect
    Inheritance: XL Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 11 ACMG points.

PVS1
For more information check the summary or visit ClinGen Evidence Repository.
PS4
For more information check the summary or visit ClinGen Evidence Repository.
PM2
For more information check the summary or visit ClinGen Evidence Repository.
PP4
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000133.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F9
NM_000133.4
MANE Select
c.880C>Tp.Arg294*
stop_gained
Exon 8 of 8NP_000124.1
F9
NM_001313913.2
c.766C>Tp.Arg256*
stop_gained
Exon 7 of 7NP_001300842.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F9
ENST00000218099.7
TSL:1 MANE Select
c.880C>Tp.Arg294*
stop_gained
Exon 8 of 8ENSP00000218099.2
F9
ENST00000394090.2
TSL:1
c.766C>Tp.Arg256*
stop_gained
Exon 7 of 7ENSP00000377650.2
F9
ENST00000643157.1
n.1547C>T
non_coding_transcript_exon
Exon 6 of 7

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
Cov.:
29
GnomAD4 genome
Cov.:
23
Alfa
AF:
0.0000387
Hom.:
0

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:8
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Hereditary factor IX deficiency disease Pathogenic:4
Apr 01, 1989
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

Dec 27, 2023
3billion
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through protein truncation. Multiple pathogenic variants are reported in the predicted truncated region. The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 22544209, 26612714). The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000010587 /PMID: 2270538). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.

Feb 09, 2024
ClinGen Coagulation Factor Deficiency Variant Curation Expert Panel, Clingen
Significance:Pathogenic
Review Status:reviewed by expert panel
Collection Method:curation

The F9 c.880C>T (Arg294Ter) variant occurs in exon 8/8 of the F9 gene, and NMD is not predicted. PVS1_Strong is applied based on truncation of the Peptidase S1 domain. This variant is completely absent from gnomAD v2.1.1 and v3.1.1, meeting PM2_Supporting criteria. Over 90 patients have been reported in the literature and the EAHAD database with hemophilia B in the moderate-severe range and history of inhibitors to factor replacement products are reported, meeting PP4_Moderate and PS4_Very strong (selected PMIDs: 29296726, 8217825, 8314564). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_VeryStrong, PVS1_Strong, PP4_Moderate, PM2_Supporting.

Jul 01, 2023
Division of Human Genetics, National Health Laboratory Service/University of the Witwatersrand
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

not provided Pathogenic:2
Oct 03, 2024
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nonsense variant predicted to result in protein truncation, as the last 168 amino acids are lost, and other loss-of-function variants have been reported downstream in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31589614, 28270892, 27109384, 38196513, 33760382, 2270538, 31064749, 35842956, 26612714, 22618954, 8314564, 8217825, 34590426, 36347023, 22544209, 10595634, 24375831, 33999344)

Mar 21, 2024
Mayo Clinic Laboratories, Mayo Clinic
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PP5, PM2_moderate, PS4_moderate, PVS1

not specified Pathogenic:1
Jun 13, 2019
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The F9 c.880C>T; p.Arg294Ter variant (rs137852248), also known as p.Arg248Ter in traditional nomenclature, is reported in the literature in multiple individuals affected with moderate to severe hemophilia B (Factor IX database and references therein). This variant is reported as pathogenic in ClinVar (Variation ID: 10587), and is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. This variant results in a premature termination codon in the last exon of the F9 gene. While this may not lead to nonsense-mediated decay, it is expected to create a truncated protein, and other downstream nonsense variants have been reported in individuals with hemophilia and are considered pathogenic (Factor IX database and references therein). Based on available information, the p.Arg294Ter variant is considered to be pathogenic. References: Factor IX database: http://www.factorix.org/

Hereditary factor IX deficiency disease;C2749016:Thrombophilia, X-linked, due to factor 9 defect Pathogenic:1
Jul 25, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Arg294*) in the F9 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 168 amino acid(s) of the F9 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with haemophilia (PMID: 2270538, 8217825, 8314564, 10595634, 22544209, 23093250, 24375831, 26612714). This variant is also known as p.Arg248*. ClinVar contains an entry for this variant (Variation ID: 10587). For these reasons, this variant has been classified as Pathogenic.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.74
D
BayesDel_noAF
Pathogenic
0.28
CADD
Pathogenic
34
DANN
Uncertain
1.0
FATHMM_MKL
Benign
0.23
N
PhyloP100
1.1
Vest4
0.89
GERP RS
3.5
Mutation Taster
=1/199
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137852248; hg19: chrX-138643724; API